Hydrocortisone May Lower Severe CAP Mortality

Network meta-analysis suggests hydrocortisone may offer mortality and ventilation benefits, although evidence certainty remained low.

Category	Detail
Condition
Key Mechanisms	Hydrocortisone associated with lower all-cause mortality compared to placebo; other corticosteroids did not show this effect.
Target Population
Care Setting

Findings based on indirect comparisons; low certainty of evidence due to imprecision and heterogeneity.

Consider hydrocortisone for severe CAP patients; however, current treatment guidelines remain unchanged due to low certainty of evidence.

Patients with severe CAP requiring intensive care.

Low-to-moderate doses and short courses of hydrocortisone may reduce mortality and mechanical ventilation needs.

Use hydrocortisone cautiously in severe CAP patients; interpret subgroup analyses with caution due to limited statistical power.

Clinical Scorecard: Hydrocortisone May Lower Severe CAP Mortality